A case of non-neutropenic invasive pulmonary aspergillosis under immune checkpoint inhibitor therapy for malignant melanoma
The patient was a 70-year-old man with diabetes mellitus, alcoholic liver disease and bronchial asthma treated with corticosteroid and long-acting β-agonist inhalants. He had also been treated with nivolumab for advanced malignant melanoma for two years with a partial response. He presented to our d...
Main Authors: | Yoshinori Uchida, So Shimamura, Shuichiro Ide, Kazuki Masuda, Masafumi Saiki, Yusuke Sogami, Hiroshi Ishihara |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Respiratory Medicine Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007122000491 |
Similar Items
-
Metagenomic next-generation sequencing for the diagnosis of pulmonary aspergillosis in non-neutropenic patients: a retrospective study
by: Shujun Bao, et al.
Published: (2022-08-01) -
The changes of expressive levels of IL-17A, STAT3, and RORγt in different invasive pulmonary aspergillosis mice
by: Xu LN, et al.
Published: (2018-08-01) -
Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment
by: Alessandro Russo, et al.
Published: (2020-07-01) -
Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?
by: Gemma E. Hayes, et al.
Published: (2016-06-01) -
Pseudomembranous aspergillar tracheobronchitis in a non-neutropenic critically ill patient in the intensive care unit
by: Sameen Khalid, et al.
Published: (2017-01-01)